- Price
- $146.23
- Day
- -3.69%
- Mkt Cap
- $14.70B
- 52W Range
- $122.14 – $186.12
- Volume
- 2.82M
- Beta
- 0.38
Find a company by name or ticker and open its page
Snapshot of fundamentals, performance, and 5D scores.
Business fundamentals and company information
Recent price action and historical returns
How the business makes money, by product and geography
Five lenses on the stock. Click any card to dive deeper.
How to read these dimensions
The five dimensions are independent lenses on a company, not a single combined score. Read them together rather than in isolation: where one dimension scores differently from the others is often the most useful place to focus your own research. Each score is built from rules and weights you can adjust, so treat them as a transparent starting point for your analysis, not a recommendation to buy or sell.
Recent news headlines and analyst price-target moves
Corient Private Wealth LP Buys 9,645 Shares of Neurocrine Biosciences, Inc. $NBIX
Corient Private Wealth LP increased its position in shares of Neurocrine Biosciences, Inc. (NASDAQ: NBIX) by 21.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 54,680 shares of the company's stock after purchasing an additional 9,645 shares during
Integrated Wealth Concepts LLC Sells 5,703 Shares of Neurocrine Biosciences, Inc. $NBIX
Integrated Wealth Concepts LLC lowered its position in Neurocrine Biosciences, Inc. (NASDAQ: NBIX) by 41.5% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 8,041 shares of the company's stock after selling 5,703 shares during the period. Integrated Wealth Concepts
Neurocrine Biosciences, Inc. (NBIX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Neurocrine Biosciences, Inc. (NBIX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Engineers Gate Manager LP Increases Holdings in Neurocrine Biosciences, Inc. $NBIX
Engineers Gate Manager LP raised its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ: NBIX) by 64.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,361 shares of the company's stock after purchasing an additional 7,163 shares during the period.
Amundi Has $37.16 Million Position in Neurocrine Biosciences, Inc. $NBIX
Amundi lifted its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ: NBIX) by 8.3% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 220,463 shares of the company's stock after purchasing an additional 16,826 shares during the quarter. Amundi owned 0.22% of